Latest Insider Transactions at Ani Pharmaceuticals Inc (ANIP)
This section provides a real-time view of insider transactions for Ani Pharmaceuticals Inc (ANIP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANI PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANI PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2023
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
250
-0.66%
|
$13,000
$52.03 P/Share
|
|
Nov 10
2023
|
Christopher Mutz HEAD OF RARE DISEASE |
SELL
Open market or private sale
|
Direct |
3,000
-4.5%
|
$156,000
$52.47 P/Share
|
|
Oct 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
10,000
-0.96%
|
$570,000
$57.06 P/Share
|
|
Oct 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,242
-0.6%
|
$355,794
$57.78 P/Share
|
|
Oct 17
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
8,758
-0.83%
|
$507,964
$58.53 P/Share
|
|
Oct 16
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
13,063
-1.22%
|
$757,654
$58.31 P/Share
|
|
Oct 13
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
11,937
-1.1%
|
$680,409
$57.58 P/Share
|
|
Oct 02
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-6.39%
|
$1,120,000
$56.48 P/Share
|
|
Sep 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,333
-2.29%
|
$1,545,313
$61.23 P/Share
|
|
Sep 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
8,425
-0.75%
|
$513,925
$61.64 P/Share
|
|
Sep 15
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
16,242
-1.43%
|
$1,007,004
$62.81 P/Share
|
|
Sep 12
2023
|
Krista Davis SVP, CHIEF HR OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,486
-4.05%
|
$90,646
$61.91 P/Share
|
|
Sep 08
2023
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,646
-1.03%
|
$222,406
$61.94 P/Share
|
|
Sep 01
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-6.0%
|
$1,280,000
$64.7 P/Share
|
|
Aug 29
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,000
-2.16%
|
$1,575,000
$63.37 P/Share
|
|
Aug 28
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,000
-2.11%
|
$1,575,000
$63.06 P/Share
|
|
Aug 23
2023
|
Ori Gutwerg SVP, GENERICS |
SELL
Open market or private sale
|
Direct |
15,561
-10.46%
|
$964,782
$62.39 P/Share
|
|
Aug 23
2023
|
Ori Gutwerg SVP, GENERICS |
BUY
Exercise of conversion of derivative security
|
Direct |
13,502
+15.01%
|
$418,562
$31.49 P/Share
|
|
Aug 23
2023
|
James G. Marken SVP OPS & PROD DEV |
SELL
Open market or private sale
|
Direct |
3,932
-2.87%
|
$247,716
$63.0 P/Share
|
|
Aug 23
2023
|
James G. Marken SVP OPS & PROD DEV |
BUY
Exercise of conversion of derivative security
|
Direct |
5,417
+1.95%
|
$195,012
$36.8 P/Share
|
|
Aug 21
2023
|
Matthew J Leonard Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,583
+50.0%
|
-
|
|
Aug 16
2023
|
Meridian Venture Partners Ii LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-9.9%
|
$11,600,000
$58.5 P/Share
|
|
Aug 15
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
22,110
-1.84%
|
$1,348,710
$61.6 P/Share
|
|
Aug 15
2023
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
11,616
-3.18%
|
$708,576
$61.13 P/Share
|
|
Aug 15
2023
|
Nikhil Lalwani PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,616
+3.08%
|
$336,864
$29.0 P/Share
|
|
Aug 14
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
27,890
-2.26%
|
$1,701,290
$61.15 P/Share
|
|
Aug 14
2023
|
Stephen P. Carey SVP & CFO |
SELL
Open market or private sale
|
Direct |
17,639
-10.17%
|
$1,075,979
$61.37 P/Share
|
|
Aug 14
2023
|
Antonio R Pera Director |
SELL
Open market or private sale
|
Direct |
3,000
-8.19%
|
$180,000
$60.37 P/Share
|
|
Aug 11
2023
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
56,666
-13.82%
|
$3,229,962
$57.75 P/Share
|
|
Aug 01
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-5.66%
|
$1,020,000
$51.06 P/Share
|
|
Jul 21
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
11,500
-0.92%
|
$598,000
$52.56 P/Share
|
|
Jul 20
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,000
-0.48%
|
$306,000
$51.52 P/Share
|
|
Jul 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
5,969
-0.48%
|
$304,419
$51.48 P/Share
|
|
Jul 18
2023
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,743
-4.41%
|
$88,893
$51.89 P/Share
|
|
Jul 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,700
-0.53%
|
$341,700
$51.84 P/Share
|
|
Jul 17
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
9,831
-0.77%
|
$501,381
$51.06 P/Share
|
|
Jul 14
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
10,000
-0.78%
|
$500,000
$50.43 P/Share
|
|
Jul 03
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-5.36%
|
$1,060,000
$53.43 P/Share
|
|
Jun 22
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-5.09%
|
$1,020,000
$51.32 P/Share
|
|
Jun 22
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Direct |
13,500
-64.57%
|
$688,500
$51.38 P/Share
|
|
Jun 21
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Direct |
11,843
-36.16%
|
$603,993
$51.95 P/Share
|
|
Jun 20
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Direct |
14,657
-30.92%
|
$747,507
$51.93 P/Share
|
|
May 23
2023
|
Antonio R Pera Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+15.78%
|
-
|
|
May 23
2023
|
Thomas Haughey Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+12.72%
|
-
|
|
May 23
2023
|
David Nash Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+15.11%
|
-
|
|
May 23
2023
|
Jeanne Thoma Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+15.94%
|
-
|
|
May 23
2023
|
Patrick D Walsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+8.9%
|
-
|
|
May 23
2023
|
Renee P Tannenbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+25.35%
|
-
|
|
Apr 10
2023
|
James G. Marken SVP OPS & PROD DEV |
SELL
Payment of exercise price or tax liability
|
Direct |
2,289
-1.71%
|
$86,982
$38.5 P/Share
|
|
Apr 10
2023
|
Stephen P. Carey SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,534
-2.55%
|
$172,292
$38.5 P/Share
|